[On biocontrolled dosages in the therapy of experimental cardiovascular insufficiency].
D000255:Adenosine Triphosphate / Q000627:therapeutic use*; D000818:Animals; D008725:Bis-Trimethylammonium Compounds; D002110:Caffeine; D002415:Cats; D004837:Epinephrine; D005730:Ganglionic Blockers; D007275:Injections, Intravenous; D009638:Norepinephrine / Q000627:therapeutic use*; D010461:Peptones; D010656:Phenylephrine / Q000627:therapeutic use*; D012769:Shock / Q000139:chemically induced / Q000188:drug therapy*; D013328:Strophanthins / Q000627:therapeutic use*; D013997:Time Factors
D008725:Bis-Trimethylammonium Compounds; D005730:Ganglionic Blockers; D010461:Peptones; D013328:Strophanthins; D010656:Phenylephrine; D002110:Caffeine; D000255:Adenosine Triphosphate; D009638:Norepinephrine; D004837:Epinephrine
O bioupravliaemom dozirovanii v terapii éksperimental'noĭ serdechno--sosudistoĭ nedostatochnosti.